These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26297207)

  • 21. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Kostková H; Etrych T; Ríhová B; Kostka L; Starovoytová L; Kovář M; Ulbrich K
    Macromol Biosci; 2013 Dec; 13(12):1648-60. PubMed ID: 24031022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
    Pike DB; Ghandehari H
    Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
    Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
    J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing Accumulation and Penetration of HPMA Copolymer-Doxorubicin Conjugates in 2D and 3D Prostate Cancer Cells via iRGD Conjugation with an MMP-2 Cleavable Spacer.
    Peng ZH; Kopeček J
    J Am Chem Soc; 2015 Jun; 137(21):6726-9. PubMed ID: 25963409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between linear and star-like HPMA conjugated pirarubicin (THP) in pharmacokinetics and antitumor activity in tumor bearing mice.
    Nakamura H; Koziolová E; Etrych T; Chytil P; Fang J; Ulbrich K; Maeda H
    Eur J Pharm Biopharm; 2015 Feb; 90():90-6. PubMed ID: 25460144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Etrych T; Strohalm J; Kovár L; Kabesová M; Ríhová B; Ulbrich K
    J Control Release; 2009 Nov; 140(1):18-26. PubMed ID: 19632282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy.
    Etrych T; Kovář L; Strohalm J; Chytil P; Ríhová B; Ulbrich K
    J Control Release; 2011 Sep; 154(3):241-8. PubMed ID: 21699933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.
    Ríhová B; Jelínková M; Strohalm J; Subr V; Plocová D; Hovorka O; Novák M; Plundrová D; Germano Y; Ulbrich K
    J Control Release; 2000 Feb; 64(1-3):241-61. PubMed ID: 10640661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Free paclitaxel-loaded E-selectin binding peptide modified micelle self-assembled from hyaluronic acid-paclitaxel conjugate inhibit breast cancer metastasis in a murine model.
    Han X; Dong X; Li J; Wang M; Luo L; Li Z; Lu X; He R; Xu R; Gong M
    Int J Pharm; 2017 Aug; 528(1-2):33-46. PubMed ID: 28576551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymeric nanomedicine for tumor-targeted combination therapy to elicit synergistic genotoxicity against prostate cancer.
    Yang Q; Yang Y; Li L; Sun W; Zhu X; Huang Y
    ACS Appl Mater Interfaces; 2015 Apr; 7(12):6661-73. PubMed ID: 25775367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
    Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
    Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced intracellular and intranuclear drug delivery mediated by biomimetic peptide SVS-1 for anticancer therapy.
    Xiang Y; Chen L; Zhou R; Huang Y
    Int J Pharm; 2019 Oct; 570():118668. PubMed ID: 31494237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation.
    Yu KF; Zhang WQ; Luo LM; Song P; Li D; Du R; Ren W; Huang D; Lu WL; Zhang X; Zhang Q
    Int J Nanomedicine; 2013; 8():2473-85. PubMed ID: 23885174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A smart polymeric platform for multistage nucleus-targeted anticancer drug delivery.
    Zhong J; Li L; Zhu X; Guan S; Yang Q; Zhou Z; Zhang Z; Huang Y
    Biomaterials; 2015 Oct; 65():43-55. PubMed ID: 26142775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting prostate carcinoma by G3-C12 peptide conjugated N-(2-hydroxypropyl)methacrylamide copolymers.
    Yang Y; Li L; Zhou Z; Yang Q; Liu C; Huang Y
    Mol Pharm; 2014 Oct; 11(10):3251-60. PubMed ID: 24955652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
    Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
    Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.